ATE283042T1 - Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel - Google Patents

Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel

Info

Publication number
ATE283042T1
ATE283042T1 AT99962490T AT99962490T ATE283042T1 AT E283042 T1 ATE283042 T1 AT E283042T1 AT 99962490 T AT99962490 T AT 99962490T AT 99962490 T AT99962490 T AT 99962490T AT E283042 T1 ATE283042 T1 AT E283042T1
Authority
AT
Austria
Prior art keywords
diisopropylphenol
dianhydro
glucitol
solvents
methyl
Prior art date
Application number
AT99962490T
Other languages
English (en)
Inventor
Dinesh Shantilal Patel
Shashikant Prabhudas Kurani
Original Assignee
Dinesh Shantilal Patel
Shashikant Prabhudas Kurani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dinesh Shantilal Patel, Shashikant Prabhudas Kurani filed Critical Dinesh Shantilal Patel
Application granted granted Critical
Publication of ATE283042T1 publication Critical patent/ATE283042T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
AT99962490T 1999-01-28 1999-09-13 Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel ATE283042T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN65BO1999 1999-01-28
PCT/IN1999/000044 WO2000044369A1 (en) 1999-01-28 1999-09-13 Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent

Publications (1)

Publication Number Publication Date
ATE283042T1 true ATE283042T1 (de) 2004-12-15

Family

ID=11077269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99962490T ATE283042T1 (de) 1999-01-28 1999-09-13 Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel

Country Status (9)

Country Link
US (1) US6071974A (de)
EP (1) EP1143962B1 (de)
CN (1) CN1151782C (de)
AT (1) ATE283042T1 (de)
AU (1) AU1888700A (de)
DE (1) DE69922252T2 (de)
ES (1) ES2232195T3 (de)
PT (1) PT1143962E (de)
WO (1) WO2000044369A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (de) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
AU2003260943A1 (en) * 2003-06-10 2005-01-04 Shashikant Prabhudas Kurani Improved novel, clear, painless preparation of propofol
US20080171687A1 (en) * 2004-09-16 2008-07-17 Abraxis Bioscience, Inc. Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
BRPI0615292A8 (pt) * 2005-08-31 2018-03-06 Abraxis Bioscience Llc composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
DK3311805T3 (da) * 2005-08-31 2020-04-14 Abraxis Bioscience Llc Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
WO1996006618A1 (en) * 1994-09-01 1996-03-07 Pharmacia & Upjohn Company Cosolvent parenteral formulation of tirilazad
IL115742A (en) * 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
CH692322A5 (it) * 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.

Also Published As

Publication number Publication date
EP1143962A1 (de) 2001-10-17
EP1143962B1 (de) 2004-11-24
US6071974A (en) 2000-06-06
CN1334725A (zh) 2002-02-06
DE69922252D1 (de) 2004-12-30
DE69922252T2 (de) 2005-12-01
ES2232195T3 (es) 2005-05-16
AU1888700A (en) 2000-08-18
WO2000044369A1 (en) 2000-08-03
CN1151782C (zh) 2004-06-02
PT1143962E (pt) 2005-03-31

Similar Documents

Publication Publication Date Title
GB0117583D0 (en) Novel compounds
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
DE69739049D1 (de) Flüssigkristallverbindungen, Flüssigkristalle enthaltende Zubereitungen, und aus diesen Verbindungen hergestellte Flüssigkristallanzeigen
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
CA2420996A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
AU2002317829A1 (en) Photostable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
WO2007099162A3 (fr) Derive de resveratrol a longue chaine hydroxylee utiles comme neurotrophiques
AR053559A1 (es) Compuestos derivados antibacterianos de 2,4' -dihidroxifenilo 3',5-disustituidos y metodos relacionados
MY140325A (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
ATE283042T1 (de) Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel
BRPI0416474A (pt) uso de um composto, composição, e compostos
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
SE0001865D0 (sv) Management of septic shock
WO1999023092A3 (en) 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
EP1390343A4 (de) Neue retinoidderivate und verfahren zur herstellung dieser verbindungen, sowie eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
RS4904A (en) Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions
CA2440186A1 (en) Medicinal composition containing 1,3-thiazine derivative
DE60237323D1 (de) Zusammensetzung enthaltend Ferrocen-Derivate und Treibstoff diese enthaltend
EA200000527A2 (ru) Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их
ITMI932193A1 (it) Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
MY133207A (en) Substituted benzolactam compaunds
WO2000067726A8 (en) Host-guest processes and formulations for delivering bio-affecting compounds
IL150100A0 (en) Pharmaceutical compositions containing fused cyclic compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1143962

Country of ref document: EP